Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

ICH M7 for Nitrosamines: Steps for a Lifecycle Management

ICH Guideline M7 provides a solid framework for the management of nitrosamines in medicinal products. By following these guidelines and implementing a comprehensive lifecycle management approach, pharmaceutical companies can effectively minimize the risks associated with nitrosamine impurities. This ensures the
  • Nitrosamine

Important Questionnaire for Nitrosamine Risk Assessment for API

The Nitrosamine Risk Assessment Questionnaire for APIs is an indispensable tool for pharmaceutical manufacturers. It provides a structured approach to identifying potential sources of nitrosamine contamination and implementing effective mitigation strategies.
  • Nitrosamine

Are Nitrosamines Hiding in Your Food? Tips to Avoid Them

Understanding the conditions that lead to nitrosamine formation is crucial for reducing their presence in our food. This article explores the science behind nitrosamine formation in cured meats and offers practical tips for minimizing their levels, ensuring a safer and
  • Nitrosamine

Top 10 Steps for Qualifying a New GMP Facility

The qualification of a GMP facility is essential to ensure the high standards of pharmaceutical production and to guarantee product quality. In our latest article, you will learn the 10 most important steps for the successful qualification of a new
  • GMP, GxP, Validation and Qualification

NDSRI Regulatory reporting requirements and their timeline

Navigating NDSRI regulatory reporting requirements is crucial for pharmaceutical companies to ensure compliance and patient safety. These regulations mandate timely and accurate reporting of nitrosamine impurities in medicines. Understanding the timeline for these requirements helps streamline processes and avoid costly
  • Nitrosamine

6 Steps to reduce nitrosamines impurities in Pharma industry

Implementing effective strategies involves six crucial steps: conducting thorough risk assessments, optimizing manufacturing processes, using high-purity raw materials, performing rigorous analytical testing, adhering to regulatory guidelines, and maintaining continuous monitoring and quality control. These measures collectively minimize nitrosamine risks in
  • Nitrosamine

The Role of Big Data in Nitrosamine Risk Assessment

In the pharmaceutical industry, nitrosamines pose significant health risks due to their carcinogenic potential. This blog explores how big data analytics revolutionizes nitrosamine risk assessment by enabling accurate monitoring and prediction. By leveraging vast datasets and predictive models, companies can
  • Nitrosamine

How Are Pharmacopoeias Protecting Medicinal Quality Across Continents?

Pharmacopoeias are essential references that ensure the quality, safety, and efficacy of medicines worldwide. They harmonize drug standards across different regions, ensuring consistent criteria for purity and potency.
  • GMP, GxP
How To Start with Nitrosamines: A Comprehensive Guide for Pharmaceutical Manufacturers

Cleaning Validation: 8 Steps for FDA Compliance Success

Cleaning validation is crucial for FDA compliance in pharmaceutical and food industries, ensuring equipment cleanliness to prevent contamination. It involves meticulous planning, execution, and documentation to verify effectiveness and consistency. Failure to comply can lead to compromised product quality, recalls,
  • Cleaning Validation, Validation and Qualification

Steps and Tips for Streamlining Medical Devices Complaint Process

Complaint handling is an integral part of medical device companies’ Quality Management System (QMS). It involves receiving, investigating, and resolving customer complaints related to medical device products and services provided by an organization. Such complaints are related to the safety,
  • Complaint management, Medical Devices